Scarica l'app Stockscreener
110.24
2.86%
-3.24
Dopo l'orario di chiusura:
110.24
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché A Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$113.48
Aprire:
$113.53
Volume 24 ore:
1.26M
Relative Volume:
0.58
Capitalizzazione di mercato:
$31.15B
Reddito:
$7.07B
Utile/perdita netta:
$1.29B
Rapporto P/E:
24.31
EPS:
4.5355
Flusso di cassa netto:
$993.00M
1 W Prestazione:
-0.95%
1M Prestazione:
-9.18%
6M Prestazione:
-10.66%
1 anno Prestazione:
-7.34%
Intervallo 1D:
$109.90
$113.73
Intervallo di 1 settimana:
$109.90
$116.40
Portata 52W:
$96.43
$160.27
Agilent Technologies Inc Stock (A) Company Profile
Nome
Agilent Technologies Inc
Settore
Industria
Telefono
(408) 345-8886
Indirizzo
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Compare A vs TMO, DHR, IDXX, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
A
Agilent Technologies Inc
|
110.24 | 31.15B | 7.07B | 1.29B | 993.00M | 4.5355 |
TMO
Thermo Fisher Scientific Inc
|
473.36 | 175.85B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
181.52 | 128.46B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
558.32 | 44.46B | 4.30B | 1.06B | 1.04B | 13.08 |
WAT
Waters Corp
|
289.16 | 28.37B | 3.17B | 642.63M | 516.49M | 10.77 |
Agilent Technologies Inc Stock (A) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-20 | Iniziato | HSBC Securities | Buy |
| 2026-01-05 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-12-15 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-12-09 | Iniziato | Goldman | Buy |
| 2025-12-02 | Iniziato | Morgan Stanley | Overweight |
| 2025-10-08 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-10-08 | Aggiornamento | UBS | Neutral → Buy |
| 2025-02-10 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-07-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-06-27 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-04-05 | Aggiornamento | Stifel | Hold → Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-12-12 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-11-17 | Downgrade | UBS | Buy → Neutral |
| 2023-09-28 | Iniziato | Bernstein | Mkt Perform |
| 2023-07-31 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-05-24 | Reiterato | Barclays | Equal Weight |
| 2023-05-24 | Reiterato | BofA Securities | Buy |
| 2023-05-24 | Reiterato | Citigroup | Neutral |
| 2023-05-24 | Reiterato | Credit Suisse | Outperform |
| 2023-05-24 | Reiterato | Evercore ISI | Outperform |
| 2023-05-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-24 | Reiterato | Robert W. Baird | Outperform |
| 2023-05-24 | Reiterato | SVB Securities | Outperform |
| 2023-05-24 | Reiterato | Stifel | Hold |
| 2023-05-24 | Reiterato | TD Cowen | Outperform |
| 2023-05-24 | Reiterato | Wells Fargo | Overweight |
| 2023-05-11 | Iniziato | Barclays | Equal Weight |
| 2023-01-10 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-07-20 | Iniziato | UBS | Buy |
| 2022-07-08 | Downgrade | Citigroup | Buy → Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-02-23 | Reiterato | BofA Securities | Buy |
| 2022-02-23 | Reiterato | Citigroup | Buy |
| 2022-02-23 | Reiterato | Cowen | Outperform |
| 2022-02-23 | Reiterato | Evercore ISI | Outperform |
| 2022-02-23 | Reiterato | Stifel | Hold |
| 2022-02-23 | Reiterato | Wells Fargo | Overweight |
| 2021-11-23 | Reiterato | BofA Securities | Buy |
| 2021-11-23 | Reiterato | Cowen | Outperform |
| 2021-11-23 | Reiterato | Stifel | Hold |
| 2021-03-18 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-02-17 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-25 | Aggiornamento | UBS | Neutral → Buy |
| 2020-11-17 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-09-30 | Iniziato | Atlantic Equities | Neutral |
| 2020-08-19 | Reiterato | BofA Securities | Neutral |
| 2020-08-19 | Reiterato | Citigroup | Neutral |
| 2020-08-19 | Reiterato | Jefferies | Buy |
| 2020-08-19 | Reiterato | Robert W. Baird | Outperform |
| 2020-08-19 | Reiterato | SVB Leerink | Outperform |
| 2020-08-19 | Reiterato | Stifel | Hold |
| 2020-08-19 | Reiterato | Wells Fargo | Overweight |
| 2020-02-24 | Downgrade | Needham | Buy → Hold |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Neutral |
| 2019-11-26 | Reiterato | Needham | Buy |
| 2019-11-15 | Iniziato | Stifel | Hold |
| 2019-10-18 | Downgrade | UBS | Buy → Neutral |
| 2019-07-16 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-07-15 | Downgrade | Barclays | Overweight → Equal Weight |
Mostra tutto
Agilent Technologies Inc Borsa (A) Ultime notizie
Agilent Technologies (A) to acquire Biocare Medical for $950M - msn.com
Agilent Technologies Inc. stock outperforms competitors despite losses on the day - MarketWatch
Why Is Agilent (A) Down 6.2% Since Last Earnings Report? - Yahoo! Finance Canada
Is It Time To Consider Buying Agilent Technologies, Inc. (NYSE:A)? - Yahoo Finance
There's A Lot To Like About Agilent Technologies' (NYSE:A) Upcoming US$0.255 Dividend - simplywall.st
Agilent receives FDA approval for PD-L1 1HC 22C3 pharmDx - Yahoo Finance
Agilent Technologies Inc. stock: Precision instruments leader navigating life sciences and diagnosti - AD HOC NEWS
Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Esophageal or Gastroesophageal Junction (GEJ) Carcinoma - BioSpace
Vanguard disaggregates holdings after realignment — Agilent (NYSE: A) - Stock Titan
Agilent Technologies (A) Gains FDA Approval for Diagnostic Tool in KEYTRUDA Treatment - GuruFocus
Agilent Technologies Inc. stock climbs on launch of advanced chromatography solutions boosting life - AD HOC NEWS
Agilent Technologies Inc. stock climbs amid new chromatography solutions launch signaling life scien - AD HOC NEWS
Agilent Technologies Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Aug Weekly: Will Agilent Technologies Inc benefit from current market trends2026 Big Picture & Momentum Based Trading Signals - baoquankhu1.vn
Pensionfund Sabic Buys New Position in Agilent Technologies, Inc. $A - MarketBeat
Agilent Technologies, Inc. (A) latest stock news and headlines - Yahoo Finance Singapore
Agilent Technologies Inc. stock rises on advanced chromatography solutions launch boosting lab effic - AD HOC NEWS
Agilent Technologies Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Agilent Technologies Inc. stock rises on advanced chromatography solutions launch boosting life scie - AD HOC NEWS
Bullish Move: Sue Rataj Shows Confidence, Acquires $241K In Agilent Technologies Stock - Benzinga
Agilent Technologies (A) to Acquire Biocare Medical for $950M - Insider Monkey
Agilent Technologies Faces Mixed Technical Signals Amid Valuation Adjustments - Markets Mojo
SG Americas Securities LLC Has $109.97 Million Position in Agilent Technologies, Inc. $A - MarketBeat
A SEC FilingsAgilent Technologies Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Agilent Q1 earnings miss estimates, revenues up Y/Y, shares fall - MSN
Agilent Technologies (A) Announces Amendments to Corporate Gover - gurufocus.com
Agilent Technologies | 4: Statement of changes in beneficial ownership of securities-Director Dolsten Mikael - Moomoo
Agilent, Axion End Cell Analysis IP Suit After Jury Selection - Law360
Agilent Technologies Launches Advanced Chromatography Solutions Enhancing Precision in Drug Developm - AD HOC NEWS
Agilent (NYSE: A) director granted 2,158 fully vested common shares - Stock Titan
Agilent (NYSE: A) director Otis Brawley granted vested stock awards - Stock Titan
Director George Scangos gets 3,215 Agilent (NYSE: A) shares - Stock Titan
Director at Agilent (NYSE: A) gets stock grant, surrenders shares for tax - Stock Titan
Agilent (NYSE: A) director Wilson Dow reports fully vested stock grant - Stock Titan
Agilent (NYSE: A) director receives 2,158-share stock award, defers receipt - Stock Titan
Agilent Technologies | 4: Statement of changes in beneficial ownership of securities-Director KOH BOON HWEE - Moomoo
Agilent (NYSE: A) director granted shares and withholds stock for taxes - Stock Titan
Agilent (NYSE: A) director granted 2,158 fully vested shares, holds 7,138 - Stock Titan
Agilent (NYSE: A) director Judy Brown granted 2,158 fully vested shares - Stock Titan
Agilent (NYSE: A) director Mala Anand granted 2,158 fully vested shares - Stock Titan
Agilent, Axion Nix Patent Trial, Pause Cases as They Near Deal - Bloomberg Law News
Agilent Technologies, Inc. (A) Stock Price, News, Quote & History - Yahoo Finance
Nordea Investment Management AB Sells 106,321 Shares of Agilent Technologies, Inc. $A - MarketBeat
Agilent Technologies Advances Chromatography Innovations for Pharma and Biotech Efficiency in 2026 - AD HOC NEWS
Agilent Technologies Advances Chromatography Innovations for Pharma and Biotech in 2026 - AD HOC NEWS
Agilent, Danaher could be potential buyers of Qiagenanalyst - MSN
Agilent Technologies Powers Art Conservation Workshop at Yale University - Yahoo
Agilent’s USCAP 2026 Pathology Updates Deepen Oncology Diagnostics Narrative - Sahm
Dividend Watch: Whats the beta of Agilent Technologies Inc stockMarket Sentiment Review & Reliable Entry Point Alerts - baoquankhu1.vn
Agilent Shareholders Approve Board Declassification and Governance Changes - TipRanks
Agilent (NYSE: A) holders back board declassification and pay votes - Stock Titan
Agilent Technologies Inc Azioni (A) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.79%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):